The Hereditary Neuropathy Foundation (HNF) proudly announces its new national network designating medical Centers of Excellence (COE) for the hereditary neuropathy patient community.  The designated COEs   demonstrate strengths in providing excellence in clinical care and research and will collaborate with HNF to expand their role as CMT/IN patient community hubs forclinical care, community engagement, research, and training/education. 

**Pharnext announced the opening of U.S. trial sites for its PLEO-CMT pivotal Phase 3 clinical trial of its lead pleodrug PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A). Locations noted in red below.

KANSAS

Currently accepting patients

University of Kansas Medical Center
Landon Center on Aging
3599 Rainbow Boulevard
Mailstop 7008
Kansas City, KS 66160

Contact:
Nicole Jenci
Phone:  913-945-9934
E-Mail: njenci@kumc.edu

Share This